Dnes je streda 19. júna 2019. Sviatok má Alfréd zajtra má sviatok Valéria .  

Domovská stránka
Ochrana osobných údajov
Nemocnica
Služby
Nadácie
Pre pacientov
Mediálne centrum
Pracovná zdravotná služba
Projekty EÚ
Výskum a vývoj
Protikorupčná linka
Podávanie sťažností
Etický kódex
Poďakovania

    


Domovská stránka arrow Mediálne centrum arrow Pozvánky - Oznamy arrow POZVÁNKA na 14. Svetový kongres o klinickej výžive
POZVÁNKA na 14. Svetový kongres o klinickej výžive Formátovať pre tlač

22 máj 2009    

Pozývame Vás na
14. Svetový kongres o klinickej výžive
a 5. Medzinárodný kongres o kardiovaskulárnych chorobách,
ktorý sa bude konať v dňoch 4.-7- júna 2009
v Double Tree by Hilton v Košiciach

Scientific Programme
14th WCCN & 5th ICCD, June 4-7, 2009, Košice, Slovakia

Thursday, June 4, 2009

13.00-14.00
ICC SYMPOSIUM I
Myocardial disease
Chaired by: Sneck J, Kumar A.

13.00-13.20
Characterisation of idiopathic dilated cardiomyopathy in Eastern Finnish population.
Tuomainen P, Finland
13.20-13.40
The treatment of chronic heart failure.
Sneck J, Finland
13.40-14.00
Left ventricular apical balloon syndrome – the new mimicry of acute myocardial infarction
Kumar A, India 

14.00-14.05
Break

14.05-15.05
ICC & ICN SYMPOSIUM I
Presidential Lectures
Chaired by: Singh RB, Ozimek L.

14.05-14.25
Inflammation and coronary artery disease
Singh RB, India
14.25-14.45
Milk protein derived peptides as a natural remedy for hypertension
Ozimek L, Canada
14.45-15.05
How coenzyme Q10 and omega-3 polyunsaturated fatty acids affect cardiovascular health
Pella D, Slovakia

15.05-15.20
COFFEE BREAK

15.20-16.25
ICC SYMPOSIUM II
New insights into lipid lowering drugs
Chaired by: Tomlinson B, Bhupendra P.

15.20-15.45
Pharmacogenetics of lipid lowering drugs: Can we improve clinical outcomes and safety by genotyping and phenotyping ?
Tomlinson B, Hong Kong
15.45-16.05
Statins in cardiovascular disease.
Iyengar S, India
16.05-16.25
Influence of coenzyme Q10 on diastolic function in statin treated patients.
Fedacko J, Slovakia

16.25-16.30
Break

16.30-17.30
ICC SYMPOSIUM III
The need of integrated approach to cardiovascular disease
Chaired by: Tkac I, Gvozdjakova A.
16.30-16.50
Cardiovascular complications of sleep apnea syndrome
Tkacova R, Slovakia  
16.50-17.10
Cardiovascular screening in diabetes
Tkac I, Slovakia
17.10-17.30
New approach of adjunctive therapy in diabetic patients
Gvozdjakova A, Slovakia

END OF SCIENTIFIC PROGRAMME DAY 1

............................................................................................................................

18.00
OPENING CEREMONY & WELCOME RECEPTION
hotel Double Tree by Hilton

Friday, June 5, 2009

SATELLITE SYMPOSIA OF PHARMA COMPANIES IN SLOVAK LANGUAGE
SATELITNÉ SYMPÓZIÁ FARMACEUTICKÝCH SPOLOČNOSTÍ – V SLOVENSKOM JAZYKU

8.30-9.30
PHARMA SYMPOSIUM I
Podporené edukačným grantom spoločnosti Astra Zeneca

8.30-8.50
TBA
Simko F
8.50-9.10
TBA
Gajdos M
9.10-9.30
TBA
Pella D

9.30-9.35
Break

9.35-10.35
PHARMA SYMPOSIUM II
Podporené edukačným grantom spoločnosti Servier

9.35-9.55
TBA
TBA
9.55-10.15
TBA
TBA
10.15-10.35
TBA
TBA

10.35-10.50
COFFEE BREAK

10.50-12.20
PHARMA SYMPOSIUM III
Podporené edukačným grantom spoločnosti Pfizer

10.50-11.10
Accuzide – ideálna kombinácia pre postmenopauzálne ženy s hypertenziou.
Šimko F, Bratislava
11.10-11.30
Potrebujú hypertonici aj  statínovú liečbu?
Gajdoš M, Bratislava
11.30-11.50
Statíny v liečbe AKS – aký statín a v akej dávke?
Pella D, Košice
11.50-12.10
Prevencia náhlej srdcovej smrti blokádou aldosterónu.
Olexa P, Košice
12.10-12.20
Diskusia

12.20-13.30
LUNCH

13.30-14.30
PHARMA SYMPOSIUM IV
Podporené edukačným grantom spoločnosti MSD
13.30-13.50
TBA
TBA
13.50-14.10
TBA
TBA
14.10-14.30
TBA
TBA

14.30-14.35
Break

14.35-15.35
PHARMA SYMPOSIUM V
Podporené edukačným grantom spoločnosti Bayer
Postavenie telmisartanu v redukcii globálneho kardiovaskulárneho rizika v liečbe hypertenzie a ICHS.
14.35-14.55
Predstavujú sartany výnimočnú alternatívu v liečbe hypertenzie ? Kombinácia excelentnej bezpečnosti a efektivity.
Fedačko J, Košice
14.55-15,15
Orgánoprotektivita – cieľ liečby hypertenzie nad rámec zníženia krvného tlaku
Juhás S, Košice
15,15-15,35
Zacielené na ONTARGET/TRANSCEND – benefit aj pre bežnú klinickú prax
Pella D, Košice

15.35-15.50
COFFEE BREAK

15.50-16.50
PHARMA SYMPOSIUM VI
Podporené edukačným grantom spoločnosti Novartis
Súčasné miesto aliskirenu -priameho renínového inhibítora - v liečbe hypertenzie a pridružených KVS komplikácií.
15.50-16.10
Hypertenzia ako terapeutický problém u staršej populácie ( AGELESS)
Fedačko J, Košice
16.10-16.30
Budúcnosť priamej renínovej inhibície z pohľadu kardioprotektivity ( PRA, ALOFT, ALLAY, ASTRONAUT, ATMOSPHERE)
TBA
16.30-16.50
Význam účinnej blokády RAS u pacientov s hypertenziou a diabetickou nefropatiou ( AVOID, ALTITUDE)
TBA

16.50-16.55
Break

16.55-17.35
PHARMA SYMPOSIUM VII
Podporené edukačnými grantami  spoločností Berlin Chemie a Teva
16.55-17.15
Nebivolol vo svetle posledných klinických štúdií
Fedačko J, Košice
17.15-17.35
Kombinácia statín-fibrát – kedy a komu ?
Pella D, Košice

END OF SCIENTIFIC PROGRAMME DAY 2

.................................................................................................. 

EVENING FOR YOUR LEISURE TIME

Saturday, June 6, 2009

8.30-9.30
SLOVAK ASSOCIATION OF ATHEROSCLEROSIS SYMPOSIUM
Dyslipidaemia and cardiovascular disease risk
Chaired by: Fabryova L, Raslova K.

8.30-8.50
Severe dyslipidaemia in pregnancy – a possible predictor of complications in patients with hypertension
Sirotiakova J, Slovakia
8.50-9.10
Relationship of triglycerides to increased cardiovascular risk
Fabryova L, Slovakia
9.10-9.30
TBA
Raslova K, Slovakia

9.30-9.35
Break

9.35-10.15
SLOVAK ASSOCIATION OF SPORTS MEDICINE SYMPOSIUM
Sports medicine and heart disease
Chaired by: Hamar D, Mesko D.

9.35-9.55
Resistance training and heart
Hamar D, Slovakia

9.55-10.15
Sudden cardiac death syndrome in athletes
Mesko D, Slovakia

10.15-10.30
COFFEE BREAK

10.30-12,30
WORLD  SOCIETY OF ANTI-AGING MEDICINE SYMPOSIUM
Anti-Aging medicine – novel field of medicine for better prevention and therapy
Chaired by: Kaltenbrunner W, Lai D.
10.30-10.50
Antiaging movement & latest evolutions.
Luino C, France
10.50-11.10
HRT and cardiovascular health.
Dalle C, France
11.10-11.30
Antiaging nutrition and lifestyle
Vogelaar E, Netherlands
11.30-11.50
Cardiovascular genetics
Kaltenbrunner W, Austria
11.50-12.10
How does genotyping affect HRT practice
Lai D, Hong Kong
12.10-12.30
Nutri-genetics and cardiovascular health
Nagy K, Hungary

12.30-13.30
LUNCH

13.30-14.20
ICN SYMPOSIUM I
Nutraceuticals in cardiovascular prevention (“Australian Session“ )
Chaired by:  Garg M, Phang M.
13.30-13.50
Nutraceuticals for reducing the risk of CVD in hyperlipidemic individuals
Garg M, Australia
13.50-14.05
Inhibition of platelet aggregation by long chain omega-3 polyunsaturated fatty acid is gender specific
Phang M, Australia
14.05-14.20
Weight loss and metabolic profiles in obese individuals using two different approaches
Munro I, Australia

14.20-14.25
Break

14.25 – 16.05 
ICN SYMPOSIUM II
Micronutrients  in health and disease
Chaired by: Littaru GP, Mortensen SA.
14.25-15.10
Biomedical and clinical  aspects of coenzyme Q10: an overview.
Littaru GP, Italy
15.10-15.30
Coenzyme Q10: An important adjunct in therapy of chronic heart failure.
Mortensen SA, Denmark
15.30-15.50
Coenzyme Q10 and selenium in the treatment of statin associated myopathy.
Pella D, Slovakia
15.50-16.10
The wine: friend or enemy
Feher J, Hungary

16.10-16.25
COFFEE BREAK

16.10-17.05
ICN SYMPOSIUM  III
Novel insights into dietary prevention of disease I.
Chaired by: Hänninen O, Hussein L.
16.10-16.30
Tomato as a functional food in helath and in disease state
Hussein L, Egypt
16.30-16.50
Benefits of traditional diets in current health problem solving 
Hänninen O, Finland
16.50-17.10
Nutrition, brain and behaviour
Gupta N, India

17.10-17.15
Break

17.15-17.55
ICN SYMPOSIUM IV
Novel insights into dietary prevention of disease II.
Chaired by: Mori H, Juneja L.
17.15-17.35
Nutritional modulation of metabolic syndrome
Mori H, Japan
17.35-17.55
Global nutraceuticals market and innovative solutions
Juneja L, Japan

END OF SCIENTIFIC PROGRAMME DAY 2

................................................................................................................

GALA DINNER
in hotel YASMIN ( detailed information about tickets availability on Registration  Counter )
Do not miss this wonderfull event. Number of tickets is limited (“first to come first to serve“)

Sunday, June 7, 2009

8.30-09.40
COLUMBUS CONCEPT SYMPOSIUM
Rationale for disease prevention - Columbus Concept hypothesis
Chaired by: DeMeester F, Singh RB.
8.30-8.50
Nutrition and psychological function. Columbus concept – the integrative approach.
Wilczynska-Kwiatek A, Poland
8.50-9.10
The TsimTsoum Concept of Holistic Health.
DeMeester F, Belgium
9.10-9.30
Proinflammatory and Antiinflammatory Foods:The Columbus Concept.
Singh Ram B, India
9.30-9.45
Omega-3 polyunsaturated fatty acids in cardiovascular disease prevention and treatment.
Pella D, Slovakia

9.45-10.00
COFFEE BREAK

10.00-11.00
ICN SYMPOSIUM V
Role of vitamins in health and disease - novel insights.
Chaired by: Basu T, Duttaroy A.
10.00-10.20
Vitamin E in the prevention of cardiovascular disease: An update.
Duttaroy A, Norway
10.20-10.40
Potential significnace and toxicities of vitamin A ( retinol) in older people
Basu T, Canada
10.40-11.00
Metabolism of vitamin B6 and its requirement in kidney diseases
Mydlik M, Slovakia

11.00-11.05
Break

11.05-12.15
ICN SYMPOSIUM VI
Miscellaneous topics I.
Chaired by: Acharya S, Mir PS.
11.05-11.25
Advances in medicinal plant research. Where should the emphasisi be in the future
Acharya S, Canada
11.25-11.45
Associations among fees withdrawal regimens, retroperitoneal and inguinal diameter and glucose tolerance in rats
Mir PS, Canada
11.45-12.00
Omega-3 fatty acids supplementation reduce incidence of lethal arrhythmias in aged male and female hypertensive rats likely due to multiple cardioprotective effects
Tribulova N, Slovakia
12.00-12.15
Digital processing and differentiation of the ultrasound liver echogenity records in patients with non alcoholic fatty liver disease - NAFLD ,using digital processing of the USG picture
Novakova B, Slovakia

12.15-12.20
Break

12.20-13.30
ICC SYMPOSIUM IV
Miscellaneous topics II.
Chaired by: Rizk HH, Shobha Rani RH. 
12.20-12.40
Impact of education and patient counseling on better management of chronic diseases viz. diabetes mellitus, hypertension and chronic renal failure
Shobha Rani R Hiremath, India
12.40-13.00
Correlates of salt excretion among hypertensive and normotensive Egyptians – analysis.
Rizk HH, Egypt
13.00-13.10
Determination of obesity and associated factors in turkish school children
Yabanci N, Turkey
13.10-13.20
Determination of factors effected dietary glycemic index in university students
Hüseyin G, Demircioglu Y, Bulduk S, Turkey
13.20-13.30
Pranayam-yoga for controlling the mind and body connection.
Singh S, India

Pridal: RNDr. Jaroslava Oravcová    
Naposledy zmenené ( 11 november 2010 )    
< Predchádzajúce   Ďalšie >
Právno-personálne inform.
Verejné obstarávanie
Nehnuteľný majetok
Tlačivá
Faktúry a objednávky
Pre zamestnancov

 
Najnovšie
Najčítanejšie

 

 
 


Louis Pasteur

©2000-2016 UNLP Košice
ISO 9001 ISO 9001